Droplet IV logo β€” Medicine belongs in patients - not in the trash! πŸ’§

Droplet IV

Medicine belongs in patients - not in the trash! πŸ’§

Founded 2022 Denmark Denmark 13 employees Non Equity Assistance Total: $1.80M Health Care, Medical Devices

General Information

Company Name Droplet IV
Founded Year 2022
Location Denmark Denmark
Employees 13
Industries Health Care, Medical Devices
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with Droplet IV. To contact Droplet IV, visit dropletiv.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Droplet IV

Droplet IV is a MedTech startup founded by doctors and engineers, currently incubated at Venture House in BioInnovation Institute. The company addresses the problem of significant underdosing of intravenous (IV) medicine, aiming to ensure that patients receive the full prescribed dose every time. With an estimated global market of over 6 billion IV infusions annually, Droplet IV offers an innovative solution, automating IV line flushing and effectively decreasing nurse tasks and multitasking. The latest funding of €1.30MConvertible Note investment at 07 March 2024 from BioInnovation Institute Venture House supports its growth. As a budding company in the Health Care industry, Droplet IV emphasizes a strong holistic company culture, prioritizing personal and professional learning. With its focus on combatting antibiotic resistance and reducing medicine waste, Droplet IV presents a promising and impactful investment opportunity.

Taxonomy: MedTech, BioMedical Design, Innovation, Medical Technology, IV Medication, Infusion Therapy, Intravenous Therapy, Nurse Shortage, Automatic Flushing, Antibiotic Resistance, Health Technology, Start-up, BioInnovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
MedTech Innovator
29 May 2024
Convertible Note €1.30M 1
BioInnovation Institute Venture House
07 Mar 2024
Pre Seed Round €500.00K 1
BioInnovation Institute Venture Lab
01 Mar 2023

Droplet IV Alternatives & Competitors

View All Alternatives
Droplet IV vs

Molecular diagnosis everywhere, at the right time and for the right price.

Grant
26 employees
Biotechnology, Health Care
Droplet IV vs

Avails Medical, Inc. - Affordable & Rapid Antibiotic Susceptibility Testing for clinical laboratorie...

Grant
51 employees
Health Care, Medical Devices
Droplet IV vs
Burnham Drugs
Burnham Drugs United States

Providing comprehensive, high-tech at-home patient care with expertly prepared medications and essen...

26 employees
Health Care, Medical Devices

FAQ About Droplet IV

Medicine belongs in patients - not in the trash! πŸ’§
Droplet IV was founded in 2022.
Droplet IV is headquartered in Denmark.
Droplet IV operates in Health Care and Medical Devices. Its work centres on MedTech, BioMedical Design, Innovation and Medical Technology.
Droplet IV has approximately 13 employees.
Droplet IV has completed 3 funding rounds, raising a total of $1.80M. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to Droplet IV include Genomtec SA, Avails Medical, Inc., Burnham Drugs, Semetron AS, EMPE Diagnostics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Droplet IV and Genomtec SA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Droplet IV, https://bouncewatch.com/company/droplet-iv, updated 17 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes